Ask AI

ARTifactual Intelligence: Enhance Your Skills in Selecting and Switching ART Regimens Through AI-Adaptive Cases

Since its inception, antiretroviral therapy (ART) for HIV has been characterized by frequent new developments and updates to best practices and guidelines. Modern ART regimens have enabled optimization of treatment for every person living with HIV, no matter their life stage or unique health needs. Boost your confidence in navigating ART initiation and ART optimization with these AI-adaptive cases, which leverage PRISM-ID, a Johns Hopkins–designed custom AI learning agent for HIV medicine, and feature personalized, adaptive educational case scenarios including assessments of knowledge and clinical reasoning.

Share

Program Content

Activities

First Steps After HIV Diagnosis
First Steps After New HIV Diagnosis
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2026

Expires: August 09, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc. and Merck & Co., Inc., Rahway, NJ, USA.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA